Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Buy
61
BRX Quote, Financials, Valuation and Earnings
Last price:
$25.74
Seasonality move
:
-0.16%
Day range:
$25.43 - $25.83
52-week range:
$22.29 - $30.67
Dividend yield:
4.41%
P/E ratio:
24.51x
P/S ratio:
6.03x
P/B ratio:
2.67x
Volume:
2.8M
Avg. volume:
2.4M
1-year change:
5.02%
Market cap:
$7.9B
Revenue:
$1.3B
EPS (TTM):
$1.05
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Revenue | $1.1B | $1.2B | $1.2B | $1.2B | $1.3B | |
| Revenue Growth (YoY) | -9.84% | 9.4% | 5.71% | 2.21% | 3.21% | |
| Cost of Revenues | $280.6M | $297.8M | $311.8M | $320M | $317.1M | |
| Gross Profit | $772.6M | $854.5M | $906.3M | $925M | $967.9M | |
| Gross Profit Margin | 73.36% | 74.16% | 74.4% | 74.3% | 75.32% | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | $98.3M | $105.5M | $117.2M | $117.1M | $116.4M | |
| Other Inc / (Exp) | -$17.6M | $43.1M | $102.3M | $50.2M | $85.1M | |
| Operating Expenses | $433.9M | $432.6M | $462M | $479.4M | $497.8M | |
| Operating Income | $338.8M | $421.9M | $444.3M | $445.6M | $470.2M | |
| Net Interest Expenses | $200M | $194.8M | $192.4M | $190.7M | $216M | |
| EBT. Incl. Unusual Items | $121.2M | $270.2M | $354.2M | $305.1M | $339.3M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | -- | -- | -- | -- | -- | |
| Net Income to Company | $121.2M | $270.2M | $354.2M | $305.1M | $339.3M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -$2K | |
| Net Income to Common Excl Extra Items | $121.2M | $270.2M | $354.2M | $305.1M | $339.3M | |
| Basic EPS (Cont. Ops) | $0.41 | $0.91 | $1.18 | $1.01 | $1.12 | |
| Diluted EPS (Cont. Ops) | $0.41 | $0.90 | $1.17 | $1.01 | $1.11 | |
| Weighted Average Basic Share | $297M | $297.4M | $299.9M | $301M | $303.1M | |
| Weighted Average Diluted Share | $297.9M | $298.8M | $301.7M | $302.4M | $304M | |
| EBITDA | $656.7M | $792.1M | $891.4M | $858.1M | $936.7M | |
| EBIT | $321.2M | $465M | $546.6M | $495.8M | $555.3M | |
| Revenue (Reported) | $1.1B | $1.2B | $1.2B | $1.2B | $1.3B | |
| Operating Income (Reported) | $338.8M | $421.9M | $444.3M | $445.6M | $470.2M | |
| Operating Income (Adjusted) | $321.2M | $465M | $546.6M | $495.8M | $555.3M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Revenue | $279.7M | $298.6M | $311.4M | $320.2M | $337.5M | |
| Revenue Growth (YoY) | -0.91% | 6.75% | 4.29% | 2.83% | 5.39% | |
| Cost of Revenues | $74.3M | $76.4M | $80.6M | $78.6M | $84.1M | |
| Gross Profit | $205.5M | $222.2M | $230.9M | $241.7M | $253.4M | |
| Gross Profit Margin | 73.45% | 74.4% | 74.13% | 75.47% | 75.08% | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | $24.6M | $28M | $29.2M | $28.5M | $28.2M | |
| Other Inc / (Exp) | $4M | $16.9M | $47M | $18.4M | $4.2M | |
| Operating Expenses | $108.1M | $112.2M | $116.9M | $119.7M | $133.8M | |
| Operating Income | $97.4M | $110M | $113.9M | $122M | $119.6M | |
| Net Interest Expenses | $49M | $47.3M | $48.7M | $51.5M | $54.1M | |
| EBT. Incl. Unusual Items | $52.4M | $79.5M | $112.2M | $88.9M | $69.7M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | -- | -- | -- | -- | -- | |
| Net Income to Company | $52.4M | $79.5M | $112.2M | $88.9M | $69.7M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -$8K | |
| Net Income to Common Excl Extra Items | $52.4M | $79.5M | $112.2M | $88.9M | $69.7M | |
| Basic EPS (Cont. Ops) | $0.18 | $0.27 | $0.37 | $0.29 | $0.23 | |
| Diluted EPS (Cont. Ops) | $0.18 | $0.26 | $0.37 | $0.29 | $0.23 | |
| Weighted Average Basic Share | $297.1M | $298.5M | $300.8M | $302M | $306.8M | |
| Weighted Average Diluted Share | $297.8M | $299.5M | $301.8M | $302.7M | $307.3M | |
| EBITDA | $184.8M | $211.1M | $248.7M | $231.6M | $229.4M | |
| EBIT | $101.4M | $126.8M | $160.9M | $140.4M | $123.8M | |
| Revenue (Reported) | $279.7M | $298.6M | $311.4M | $320.2M | $337.5M | |
| Operating Income (Reported) | $97.4M | $110M | $113.9M | $122M | $119.6M | |
| Operating Income (Adjusted) | $101.4M | $126.8M | $160.9M | $140.4M | $123.8M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Revenue | $1.1B | $1.2B | $1.2B | $1.3B | $1.3B | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | $281.7M | $300M | $315.9M | $318M | $322.7M | |
| Gross Profit | $769M | $871.2M | $915M | $935.9M | $979.7M | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | $100.3M | $108.8M | $118.4M | $116.4M | $116M | |
| Other Inc / (Exp) | -$17.3M | $56M | $132.4M | $21.6M | $70.8M | |
| Operating Expenses | $436.3M | $436.8M | $466.6M | $482.2M | $511.8M | |
| Operating Income | $332.7M | $434.4M | $448.3M | $453.7M | $467.9M | |
| Net Interest Expenses | $201.6M | $193.1M | $193.8M | $193.5M | $218.6M | |
| EBT. Incl. Unusual Items | $113.8M | $297.3M | $386.9M | $281.7M | $320.1M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | -- | -- | -- | -- | -- | |
| Net Income to Company | $113.8M | $297.3M | $386.9M | $281.7M | $320.1M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -$8K | |
| Net Income to Common Excl Extra Items | $113.8M | $297.3M | $386.9M | $281.7M | $320.1M | |
| Basic EPS (Cont. Ops) | $0.38 | $0.99 | $1.28 | $0.93 | $1.06 | |
| Diluted EPS (Cont. Ops) | $0.38 | $0.98 | $1.27 | $0.93 | $1.05 | |
| Weighted Average Basic Share | ||||||
| Weighted Average Diluted Share | ||||||
| EBITDA | $651.4M | $828.3M | $931.9M | $844.4M | $936.9M | |
| EBIT | $315.4M | $490.4M | $580.7M | $475.3M | $538.7M | |
| Revenue (Reported) | $1.1B | $1.2B | $1.2B | $1.3B | $1.3B | |
| Operating Income (Reported) | $332.7M | $434.4M | $448.3M | $453.7M | $467.9M | |
| Operating Income (Adjusted) | $315.4M | $490.4M | $580.7M | $475.3M | $538.7M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Revenue | $279.7M | $298.6M | $311.4M | $320.2M | $337.5M | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | $74.3M | $76.4M | $80.6M | $78.6M | $84.1M | |
| Gross Profit | $205.5M | $222.2M | $230.9M | $241.7M | $253.4M | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | $24.6M | $28M | $29.2M | $28.5M | $28.2M | |
| Other Inc / (Exp) | $4M | $16.9M | $47M | $18.4M | $4.2M | |
| Operating Expenses | $108.1M | $112.2M | $116.9M | $119.7M | $133.8M | |
| Operating Income | $97.4M | $110M | $113.9M | $122M | $119.6M | |
| Net Interest Expenses | $49M | $47.3M | $48.7M | $51.5M | $54.1M | |
| EBT. Incl. Unusual Items | $52.4M | $79.5M | $112.2M | $88.9M | $69.7M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | -- | -- | -- | -- | -- | |
| Net Income to Company | $52.4M | $79.5M | $112.2M | $88.9M | $69.7M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -$8K | |
| Net Income to Common Excl Extra Items | $52.4M | $79.5M | $112.2M | $88.9M | $69.7M | |
| Basic EPS (Cont. Ops) | $0.18 | $0.27 | $0.37 | $0.29 | $0.23 | |
| Diluted EPS (Cont. Ops) | $0.18 | $0.26 | $0.37 | $0.29 | $0.23 | |
| Weighted Average Basic Share | $297.1M | $298.5M | $300.8M | $302M | $306.8M | |
| Weighted Average Diluted Share | $297.8M | $299.5M | $301.8M | $302.7M | $307.3M | |
| EBITDA | $184.8M | $211.1M | $248.7M | $231.6M | $229.4M | |
| EBIT | $101.4M | $126.8M | $160.9M | $140.4M | $123.8M | |
| Revenue (Reported) | $279.7M | $298.6M | $311.4M | $320.2M | $337.5M | |
| Operating Income (Reported) | $97.4M | $110M | $113.9M | $122M | $119.6M | |
| Operating Income (Adjusted) | $101.4M | $126.8M | $160.9M | $140.4M | $123.8M | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $368.7M | $296.6M | $16.5M | $866K | $377.6M | |
| Short Term Investments | $19.5M | $20.2M | $21.7M | $19.9M | $20.3M | |
| Accounts Receivable, Net | $240.3M | $234.9M | $264.1M | $278.8M | $281.9M | |
| Inventory | -- | -- | -- | -- | -- | |
| Prepaid Expenses | -- | -- | -- | -- | -- | |
| Other Current Assets | -- | -- | -- | -- | -- | |
| Total Current Assets | $648M | $569M | $317.5M | $317.6M | $685.1M | |
| Property Plant And Equipment | -- | -- | -- | -- | -- | |
| Long-Term Investments | -- | -- | -- | -- | -- | |
| Goodwill | -- | -- | -- | -- | -- | |
| Other Intangibles | -- | -- | -- | -- | -- | |
| Other Long-Term Assets | $50.8M | $49.8M | $62.7M | $54.2M | $57.8M | |
| Total Assets | $8.3B | $8.4B | $8.4B | $8.3B | $8.9B | |
| Accounts Payable | -- | -- | -- | -- | -- | |
| Accrued Expenses | -- | -- | -- | -- | -- | |
| Current Portion Of Long-Term Debt | -- | -- | -- | -- | -- | |
| Current Portion Of Capital Lease Obligations | -- | -- | -- | -- | -- | |
| Other Current Liabilities | -- | -- | -- | -- | -- | |
| Total Current Liabilities | $1.1B | $790.9M | $951M | $1.1B | $1.1B | |
| Long-Term Debt | $4.5B | $4.9B | $4.6B | $4.4B | $4.8B | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $5.7B | $5.7B | $5.6B | $5.5B | $5.9B | |
| Common Stock | $3M | $3M | $3M | $3M | $3.1M | |
| Other Common Equity Adj | -$28.1M | -$12.7M | $8.9M | -$2.7M | $8.2M | |
| Common Equity | $2.7B | $2.7B | $2.9B | $2.9B | $3B | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | -- | -- | -- | -- | $244K | |
| Total Equity | $2.7B | $2.7B | $2.9B | $2.9B | $3B | |
| Total Liabilities and Equity | $8.3B | $8.4B | $8.4B | $8.3B | $8.9B | |
| Cash and Short Terms | $388.2M | $316.9M | $38.2M | $20.8M | $397.9M | |
| Total Debt | $5.2B | $5.2B | $5B | $4.9B | $5.3B | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $371.4M | $31.6M | $3.4M | $407.1M | $106.5M | |
| Short Term Investments | $18.7M | $19.3M | $20.6M | $19.5M | $19.9M | |
| Accounts Receivable, Net | $231.5M | $239.9M | $246.9M | $248M | $274.1M | |
| Inventory | -- | -- | -- | -- | -- | |
| Prepaid Expenses | -- | -- | -- | -- | -- | |
| Other Current Assets | -- | -- | -- | -- | -- | |
| Total Current Assets | $635.3M | $324M | $303M | $686M | $406.4M | |
| Property Plant And Equipment | -- | -- | -- | -- | -- | |
| Long-Term Investments | -- | -- | -- | -- | -- | |
| Goodwill | -- | -- | -- | -- | -- | |
| Other Intangibles | -- | -- | -- | -- | -- | |
| Other Long-Term Assets | $49.5M | $52.7M | $59.5M | $56M | $59M | |
| Total Assets | $8.3B | $8.2B | $8.4B | $8.6B | $8.6B | |
| Accounts Payable | -- | -- | -- | -- | -- | |
| Accrued Expenses | -- | -- | -- | -- | -- | |
| Current Portion Of Long-Term Debt | -- | -- | -- | -- | -- | |
| Current Portion Of Capital Lease Obligations | -- | -- | -- | -- | -- | |
| Other Current Liabilities | -- | -- | -- | -- | -- | |
| Total Current Liabilities | $458M | $557M | $555.8M | $473.8M | $1B | |
| Long-Term Debt | $5.2B | $4.9B | $4.9B | $5.3B | $4.6B | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $5.6B | $5.5B | $5.5B | $5.8B | $5.6B | |
| Common Stock | $3M | $3M | $3M | $3M | $3.1M | |
| Other Common Equity Adj | -$22.5M | -$1.7M | $5.1M | $9.5M | $4.1M | |
| Common Equity | -- | -- | -- | -- | -- | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | -- | -- | -- | -- | $252K | |
| Total Equity | $2.7B | $2.8B | $2.9B | $2.9B | $3B | |
| Total Liabilities and Equity | $8.3B | $8.2B | $8.4B | $8.6B | $8.6B | |
| Cash and Short Terms | $390.1M | $50.9M | $24.1M | $426.6M | $126.4M | |
| Total Debt | $5.2B | $5B | $5B | $5.3B | $5.1B | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $121.2M | $270.2M | $354.2M | $305.1M | $339.3M | |
| Depreciation & Amoritzation | $319.1M | $327.2M | $332.6M | $349.5M | $370.2M | |
| Stock-Based Compensation | $11M | $17.1M | $23.4M | $20.8M | $17.9M | |
| Change in Accounts Receivable | -$9.8M | $2.2M | -$32M | -$16.5M | -$8M | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | $443.1M | $552.2M | $566.4M | $588.8M | $624.7M | |
| Capital Expenditures | -- | -- | -- | -- | -- | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | -$167.2M | -$331M | -$462.5M | -$163.1M | -$437M | |
| Dividends Paid (Ex Special Dividend) | -$170.4M | -$257.2M | -$289.6M | -$315.3M | -$331.2M | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | $1.5B | $847.7M | $800M | $725.5M | $876.2M | |
| Long-Term Debt Repaid | -$1.2B | -$850M | -$925M | -$826.3M | -$465.9M | |
| Repurchase of Common Stock | -$25M | -- | -- | -- | -- | |
| Other Financing Activities | -$34.7M | -$33.7M | -$8.4M | -$783K | -$7.5M | |
| Cash From Financing | $72.7M | -$293.6M | -$380.4M | -$428.1M | $172.1M | |
| Beginning Cash (CF) | $21.5M | $370.1M | $297.7M | $21.3M | $18.9M | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | $348.6M | -$72.3M | -$276.5M | -$2.4M | $359.8M | |
| Ending Cash (CF) | $370.1M | $297.7M | $21.3M | $18.9M | $378.7M | |
| Levered Free Cash Flow | $443.1M | $552.2M | $566.4M | $588.8M | $624.7M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $52.4M | $79.5M | $112.2M | $88.9M | $69.7M | |
| Depreciation & Amoritzation | $80.5M | $81.3M | $84.4M | $88.8M | $102.3M | |
| Stock-Based Compensation | $2.6M | $4.3M | $4.2M | $3.4M | $4.1M | |
| Change in Accounts Receivable | $7.1M | -$4.7M | $15.6M | $28.6M | $9.4M | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | $110.5M | $112.3M | $135.1M | $128.5M | $130.1M | |
| Capital Expenditures | -- | -- | -- | -- | -- | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | -$34.1M | -$174.9M | $48.5M | -$9.2M | -$63.5M | |
| Dividends Paid (Ex Special Dividend) | -$65M | -$73.1M | -$80.1M | -$83.9M | -$89.5M | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | $349.4M | $210M | $117M | $479.3M | $806.3M | |
| Long-Term Debt Repaid | -$350M | -$365M | -$195M | -$98.5M | -$1B | |
| Repurchase of Common Stock | -- | -- | -- | -- | -$78K | |
| Other Financing Activities | -$3.1M | -- | -$60K | -$3.8M | -$3.7M | |
| Cash From Financing | -$73.8M | -$194.7M | -$169.4M | $280.2M | -$337.9M | |
| Beginning Cash (CF) | $370.1M | $297.7M | $21.3M | $18.9M | $378.7M | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | $2.6M | -$257.4M | $14.2M | $399.5M | -$271.3M | |
| Ending Cash (CF) | $372.7M | $40.4M | $35.4M | $418.4M | $107.4M | |
| Levered Free Cash Flow | $110.5M | $112.3M | $135.1M | $128.5M | $130.1M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $113.8M | $297.3M | $386.9M | $281.7M | $320.1M | |
| Depreciation & Amoritzation | $320.8M | $327.9M | $335.7M | $354M | $383.7M | |
| Stock-Based Compensation | $10.9M | $18.8M | $23.3M | $19.9M | $18.7M | |
| Change in Accounts Receivable | -$1.3M | -$9.6M | -$11.7M | -$3.5M | -$27.2M | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | $458.5M | $554M | $589.2M | $582.3M | $626.3M | |
| Capital Expenditures | -- | -- | -- | -- | -- | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | -$154.8M | -$471.8M | -$239M | -$220.7M | -$491.3M | |
| Dividends Paid (Ex Special Dividend) | -$149.8M | -$265.4M | -$296.6M | -$319.1M | -$336.8M | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | $1.2B | $708.4M | $707M | $1.1B | $1.2B | |
| Long-Term Debt Repaid | -$1.5B | -$865M | -$755M | -$729.8M | -$1.4B | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | -$37.4M | -- | -$8.4M | -$4.5M | -$7.4M | |
| Cash From Financing | -$518.2M | -$414.5M | -$355.1M | $21.5M | -$445.9M | |
| Beginning Cash (CF) | -- | -- | -- | -- | -- | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | -$214.4M | -$332.3M | -$5M | $383M | -$311M | |
| Ending Cash (CF) | -- | -- | -- | -- | -- | |
| Levered Free Cash Flow | $458.5M | $554M | $589.2M | $582.3M | $626.3M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $52.4M | $79.5M | $112.2M | $88.9M | $69.7M | |
| Depreciation & Amoritzation | $80.5M | $81.3M | $84.4M | $88.8M | $102.3M | |
| Stock-Based Compensation | $2.6M | $4.3M | $4.2M | $3.4M | $4.1M | |
| Change in Accounts Receivable | $7.1M | -$4.7M | $15.6M | $28.6M | $9.4M | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | $110.5M | $112.3M | $135.1M | $128.5M | $130.1M | |
| Capital Expenditures | -- | -- | -- | -- | -- | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | -$34.1M | -$174.9M | $48.5M | -$9.2M | -$63.5M | |
| Dividends Paid (Ex Special Dividend) | -$65M | -$73.1M | -$80.1M | -$83.9M | -$89.5M | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | $349.4M | $210M | $117M | $479.3M | $806.3M | |
| Long-Term Debt Repaid | -$350M | -$365M | -$195M | -$98.5M | -$1B | |
| Repurchase of Common Stock | -- | -- | -- | -- | -$78K | |
| Other Financing Activities | -$3.1M | -- | -$60K | -$3.8M | -$3.7M | |
| Cash From Financing | -$73.8M | -$194.7M | -$169.4M | $280.2M | -$337.9M | |
| Beginning Cash (CF) | $370.1M | $297.7M | $21.3M | $18.9M | $378.7M | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | $2.6M | -$257.4M | $14.2M | $399.5M | -$271.3M | |
| Ending Cash (CF) | $372.7M | $40.4M | $35.4M | $418.4M | $107.4M | |
| Levered Free Cash Flow | $110.5M | $112.3M | $135.1M | $128.5M | $130.1M | |
Get BRX Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
BRX
Sector
P/E ratio
24.51x
19.72x
PEG ratio
1.90x
0.10x
P/B ratio
2.67x
0.83x
Price / LTM sales
6.03x
3.52x
Growth Metrics
BRX
Sector
Revenue growth
5.39%
1.23%
Earnings growth
-20.69%
-1.15%
Revenue (5-year growth)
1.92%
2.95%
Earnings forecast
$0.21
$0.17
Profitability
BRX
Sector
Profitability FY 2024
$967.9M
$203.5M
Return on invested capital
3.9%
1.76%
Return on assets
3.67%
1.52%
Return on equity
11.01%
3.28%
Earnings Date
Last Earnings Date
Apr
29
Next Earnings Date
Jul
29
Estimated Next Earnings Date
Jul
29
Balance Sheet
BRX
Sector
Total cash
$126.4M
$68M
Short term investments
$20.3M
$13.6M
Total assets
$8.9B
$3.3B
Long term debt
$5.1B
$1.3B
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will FCX Benefit From Tariffs?
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Can Levi Stock Double?
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Stock Ideas
Buy
71
Is NVDA Stock a Buy?
Market Cap: $4.2T
P/E Ratio: 58x
Buy
51
Is MSFT Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 43x
Sell
40
Is AAPL Stock a Buy?
Market Cap: $3.1T
P/E Ratio: 35x
Alerts
Buy
82
SBET alert for Jul 18
SharpLink Gaming [SBET] is down 2.6% over the past day.
Buy
68
MCRI alert for Jul 18
Monarch Casino & Resort [MCRI] is up 19.81% over the past day.
Sell
41
NEGG alert for Jul 18
Newegg Commerce [NEGG] is up 17.85% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
